*  Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty - Full Text View - ClinicalTrials.gov
Device: Bare Metal Stent Device: Drug-Eluting Stent Drug: Blinded clopidogrel Drug: Placebo Drug: Thienopyridine (open-label) ... Device: Drug-Eluting Stent Patients receive one or more drug-eluting stents in the saphenous vein graft target lesion. ... bare metal stents (BMS) and drug-eluting stents (DES). Both BMS and DES are made of metal. DES are also coated with a drug that ... Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty (DIVA). The safety and scientific validity of ...
  https://clinicaltrials.gov/ct2/show/NCT01121224?term=cardiac+rehabilitation&recr=Open&fund=01&rank=8
*  Femtosecond Laser Nano Texturing of Drug-Eluting Stents
Drug-eluting stents (DES) have a significant impact in treating in-stent restenosis. DES are embedded with drugs like Sirolimus ... Nano-textures increase the availability of the drug, increase adhesion of the drug and the stent, and minimize requirement of a ... Stents have been used for over a decade to treat coronary arteries affected by stenosis, a state in which the arteries are ... But DES increases the risk of thrombosis, formation of blood clots around the stent due to a change in the blood flow profile. ...
  https://soar.wichita.edu/handle/10057/12935
*  Update on drug-eluting stents for prevention of restenosis | ScholarBank@NUS
More types of drug-eluting stents are expected on the market in the near future. Meanwhile, the evaluation of drug-eluting ... Lee, C.-H., Tan, H.-C., Lim, Y.-T. (2006-02). Update on drug-eluting stents for prevention of restenosis. Asian Cardiovascular ... Unprecedented results have been obtained in early clinical studies on sirolimus-eluting and paclitaxel-eluting stents. Trials ... Recently, local drug delivery has been advocated as a potential strategy to prevent in-stent restenosis. ...
  http://scholarbank.nus.edu.sg/handle/10635/130642
*  Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty - Full Text View - ClinicalTrials.gov
Device: Bare Metal Stent Device: Drug-Eluting Stent Drug: Blinded clopidogrel Drug: Placebo Drug: Thienopyridine (open-label) ... Device: Drug-Eluting Stent Patients receive one or more drug-eluting stents in the saphenous vein graft target lesion. ... bare metal stents (BMS) and drug-eluting stents (DES). Both BMS and DES are made of metal. DES are also coated with a drug that ... Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty (DIVA). This study has been completed. ...
  https://clinicaltrials.gov/ct2/show/NCT01121224?term=heart+transplant+OR+cardiac+transplant&recr=Open&fund=01&rank=16
*  NewsCAP: Drug-eluting stents work as well as bare-metal ste... : AJN The American Journal of Nursing
NewsCAP: Drug-eluting stents work as well as bare-metal stents at keeping blocked arteries open. AJN The American Journal of ... Drug-eluting stents work as well as bare-metal stents at keeping blocked arteries open, according to a meta-analysis in the ... However, patients with drug-eluting stents required revascularization nearly half as often as those with bare-metal stents. The ... NewsCAP: Drug-eluting stents work as well as bare-metal stents at keeping blocked arteries open ...
  http://journals.lww.com/ajnonline/Fulltext/2012/07000/NewsCAP___Drug_eluting_stents_work_as_well_as.10.aspx
*  Drug-Eluting Coronary Stents Utilizing Isotechnika's Lead Drug Receive Approval to Enter Clinical Trials | Medienmitteilung...
Isotechnika Inc.announced today that voclosporin is positioned to enter a Phase 1clinical trial as the drug utilized in the ... Drug-Eluting Coronary Stents Utilizing Isotechnika's Lead Drug Receive Approval to Enter Clinical Trials. 29.05.2008 - 15:08 ... technology that merges the desirable safety benefits of a bare metal stent with the clinical advantages of a drug eluting stent ... announced today that voclosporin is positioned to enter a Phase 1 clinical trial as the drug utilized in the CINATRA(TM) Drug ...
  https://www.presseportal.ch/de/pm/100005767/100562772
*  Drug-eluting Stents May Cause Allergic Reactions - Parker Waichman LLP
Drug-eluting stents have greatly reduced the risk of repeat blockage of heart disease. ... Drug-Eluting Stents Can Cause Serious Consequences. Drug-eluting stents have greatly reduced the risk of repeat blockage of ... You are here: Home / Diseases / Blood Clots / Drug-eluting Stents May Cause Allergic Reactions ... "Drug-eluting stents are a life-saving advance used by hundreds of thousands of people that have greatly reduced the risk of ...
  https://www.yourlawyer.com/diseases/blood-clots/drug-eluting-stents-may-cause-allergic-reactions/
*  Drug deposition in coronary arteries with overlapping drug-eluting stents | The Interface Group
Drug deposition in coronary arteries with overlapping drug-eluting stents. Drug-eluting stents are accepted as mainstream ... as well as on the relative positioning of drug-eluting struts. Overlapping stent struts lead to localized peaks of drug ... Such peaks could be avoided by anisotropic stent structure or asymmetric drug release designed to yield homogeneous drug ... The complex three-dimensional geometry of deployed stents together with the combination of diffusive and advective drug ...
  http://interfacegroup.ch/journal-article/drug-deposition-in-coronary-arteries-with-overlapping-drug-eluting-stents/
*  OCT-Verified Neointimal Hyperplasia Is Increased at Fracture Site in Drug-Eluting Stents | JACC: Cardiovascular Imaging
Although drug-eluting stents dramatically reduce stent restenosis, in-stent restenosis still occurs in approximately 10% of ... Stent fracture was observed in 14 (12.7%) of 110 stents. The fractured stent group showed higher binary in-stent restenosis (29 ... OCT-Verified Neointimal Hyperplasia Is Increased at Fracture Site in Drug-Eluting Stents ... OCT-Verified Neointimal Hyperplasia Is Increased at Fracture Site in Drug-Eluting Stents ...
  http://imaging.onlinejacc.org/content/5/2/232
*  Doi:10.1016/s0140-6736(09)62127-9
between comparator polymer-based drug-eluting stents. Stent thrombosis in randomised clinical trial of drug eluting stents. J ... Everolimus-eluting Paclitaxel-eluting Relative risk. stent (n=897). stent (n=903). Events at 30 days. All-cause mortality or ... Everolimus-eluting Paclitaxel-eluting Relative risk. stent (n=897). stent (n=903). Events at 12 months. All-cause mortality or ... of sirolimus-eluting and Comparison of an everolimus-eluting stent and a paclitaxel-eluting paclitaxel-eluting stents in ...
  http://pharmapdf.com/m/medicor.com.ua1.html
*  Drug-eluting stents to prevent stent thrombosis and restenosis. - NextBio article
Drug-eluting stents to prevent stent thrombosis and restenosis. Expert review of cardiovascular therapy. 2016;14(1):87-104 ... Drug-eluting stents to prevent stent thrombosis and restenosis. Eui Im, Myeong-Ki Hong ... Although first-generation drug-eluting stents (DES) have significantly reduced the risk of in-stent restenosis, they have also ... Drug-Eluting Stents Humans Immunosuppressive Agents Inventions Percutaneous Coronary Intervention Polymers Postoperative ...
  http://www.nextbio.com/b/search/article.nb?id=26567863
*  Drug-Eluting Stents: Boom or Bust? | Annals of Internal Medicine | American College of Physicians
PCI with drug-eluting stents reduced revascularizations, but not mortality or MI, compared with bare-metal stents Annals of ... PCI with drug-eluting stents reduced revascularizations, but not mortality or MI, compared with bare-metal stents Annals of ... PCI using drug-eluting stents had higher mortality than CABG in diabetes and multivessel CAD Annals of Internal Medicine; 158 ( ... PCI with drug-eluting stents ≤ 12 months before surgery was linked to increased MI and cardiac death after surgery Annals of ...
  http://annals.org/aim/article-abstract/1935058/drug-eluting-stents-boom-bust
*  Long Lesions, Hard Endpoints, and Intravascular Ultrasound | JACC: Cardiovascular Interventions
The outcomes of angiography-guided second-generation drug-eluting stent placement in high-risk PCI are quite good: at 1-year ... 2014) Intravascular ultrasound-guided implantation of drug-eluting stents to improve outcome: a meta-analysis. J Am Coll ... The present meta-analysis includes 3 randomized trials involving only second-generation drug-eluting stents and complex ... 2016) Effects of intravascular ultrasound-guided versus angiography-guided new-generation drug-eluting stent implantation: meta ...
  http://interventions.onlinejacc.org/content/9/21/2240
*  Regarding Comparison of Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for Cardiac Allograft...
This is an interesting study showing a lower in-stent restenosis rate of patients receiving drug-eluting stents (DES) for ... 2008) Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft ... Regarding Comparison of Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for Cardiac Allograft ... Regarding Comparison of Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for Cardiac Allograft ...
  http://interventions.onlinejacc.org/content/2/5/474.2
*  Drug-Eluting Stents for the Treatment of Intracranial Atherosclerosis | Stroke
Background and Purpose- Intracranial stenting is associated with a 32% rate of restenosis. Drug-eluting stents (DES) have ... but has been effectively addressed by the use of drug-eluting stents (DES).2,3 These devices release drugs that prevent the ... Drug-Eluting Stents for the Treatment of Intracranial Atherosclerosis. Initial Experience and Midterm Angiographic Follow-up. ... Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol. 2005; 45: 954 ...
  http://stroke.ahajournals.org/content/36/12/e165
*  Current and Future State of Drug-Eluting Stents
Boam of the FDA provide a comprehensive overview of drug-eluting stents, including the state of current approvals and future ... Ashley B. Boam, BSE, MSBE: Welcome to this Medscape expert commentary on drug-eluting stents (DES). I'm Ashley Boam, Chief of ... Current and Future State of Drug-Eluting Stents - Medscape - Oct 27, 2011. ... Stent thrombosis didn't originate with DES. Acute stent thrombosis, meaning stent thrombosis within the first 30 days, was an ...
  https://www.medscape.com/viewarticle/751715
*  Drug-eluting stents - CRF
Drug-eluting Stents Drug-eluting Stents. The field of interventional cardiology has made great strides in developing innovative ... Today, approximately 75% of all stents placed during an angioplasty are drug-eluting stents. ... Drug-eluting stents are coated with medicine which is slowly released into the artery to help prevent re-blockages and repeat ... Stents are small wire mesh tubes that keep clogged arteries open after an angioplasty, a non-surgical procedure that opens up ...
  http://www.crf.org/crf/advancements/drug-eluting-stents
*  Drug-eluting stent thrombosis.
... drug-eluting stents (DES) are associated with a dramatic reduction in restenosis and target lesion revascularization. However, ... Drug-eluting stents in patients with end-stage renal disease.. Next Document: Antiplatelet therapy following drug-eluting stent ... When compared to bare metal stents (BMS), drug-eluting stents (DES) are associated with a dramatic reduction in restenosis and ... Drug-Eluting Stents / adverse effects*. Humans. Incidence. Risk Factors. From MEDLINE®/PubMed®, a database of the U.S. National ...
  http://www.biomedsearch.com/nih/Drug-eluting-stent-thrombosis/18432175.html
*  Drug Eluting Stents Have Delayed Adverse Events
... bleeding and cardiac problems than a bare metal coronary stent with continued thienopyridine. ... Drug eluting stents were better at preventing thrombosis, ... A drug eluting stent, a coronary stent placed into narrowed ... Drug Toxicity. Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a drug, ... such as stent placement and 1 month of DAPT was compared with 6 to 12 months for drug-eluting stents (DES). ...
  http://www.medindia.net/news/drug-eluting-stents-have-delayed-adverse-events-147491-1.htm
*  Drug-Eluting Stent Update 2007 | Circulation
Drug-Eluting Stent Update 2007. Part I: A Survey of Current and Future Generation Drug-Eluting Stents: Meaningful Advances or ... Although only sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) have received US Food and Drug Administration ... In the Janus tacrolimus-eluting stent, the drug is embedded in reservoirs carved on the outer stent surface to release the drug ... Intracoronary Stenting and Angiographic Results-Drug-Eluting Stents for In-Stent Restenosis (ISAR-DESIRE) trial, and the ISAR- ...
  http://circ.ahajournals.org/content/116/3/316
*  Patent US7951193 - Drug-eluting stent - Google Patents
A stent for delivering therapeutic agents to a body lumen includes a plurality of circumferential serpentine bands with each ... Stent with thin drug-eluting film. EP1886703B1. 10 Jul 2007. 23 Jun 2010. BIOTRONIK VI Patent AG. Stent with a coating ... Drug-eluting stent for controlled drug delivery. US20040211362. 26 May 2004. 28 Oct 2004. Daniel Castro. System for coating a ... Drug-eluting stent for controlled drug delivery. US7163715. 30 Dec 2002. 16 Jan 2007. Advanced Cardiovascular Systems, Inc.. ...
  http://www.google.com.au/patents/US7951193
*  Drug Release Analysis and Optimization for Drug-Eluting Stents
... Hongxia Li,1 Yihao Zhang,1 Bao Zhu,2 Jinying Wu,1 and Xicheng ... The drug release analysis and optimization for drug-eluting stents in the arterial wall are studied, which involves mechanics, ... The Finite Element Method (FEM) is used to analyze the process of drug release in the vessels for drug-eluting stents (DES). ... The effect of coating diffusivity and thickness on the drug release process for a typical DES is analyzed by means of FEM. An ...
  https://www.hindawi.com/journals/tswj/2013/827839/abs/
*  Drug-Eluting Stents I
... a.k.a drug coated stents or medicated stents or DES) which explains the basics about these devices, including key vocabulary, ... For more in-depth information and late-breaking articles about drug-eluting stents, visit our Drug-Eluting Stent Center. ... 1) An introduction to drug-eluting stents (also known as "drug coated stents", "medicated stents", or "DES");. (2) A history of ... Drug-eluting stents are metal stents that have been coated with a pharmacologic agent (drug) that is known to suppress ...
  http://www.ptca.org/des.html
*  Nanoparticles - possible alternative to drug eluting stents
... By Massachusetts Institute of Technology, Jan 18, 2010 - 2:00:58 ... an advance that potentially provides an alternative to drug-releasing stents in some patients with cardiovascular disease.. The ... The drug can only be released when it detaches from the PLA polymer chain, which occurs gradually by a reaction called ester ... So far, they have achieved drug release over 12 days, in tests in cultured cells.. In tests in rats, the researchers showed ...
  http://www.rxpgnews.com/coronaryarterydisease/Nanoparticles_-_possible_alternative_to_drug_eluting_stents_printer.shtml
*  Drug Eluting Stent
... Ultimaster® - Drug eluting stent. Pushing the boundaries of science and medical engineering for the ... combines an optimal balance between stent design for ultimate conformability with simultaneous polymer resorption and drug ...
  http://www.terumo-europe.com/en-emea/interventional-cardiology/stents/drug-eluting-stent/